T. Hirano, K. Ishihara, and M. Hibi, Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors, Oncogene, vol.19, pp.2548-56, 2000.

T. Alonzi, D. Maritano, B. Gorgoni, G. Rizzuto, C. Libert et al., Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation, Mol Cell Biol, vol.21, pp.1621-1653, 2001.

R. Raz, J. E. Durbin, and D. E. Levy, Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors, J Biol Chem, vol.269, pp.24391-24396, 1994.

Z. Zhong, Z. Wen, and J. E. Darnell, Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6, Science, vol.264, pp.95-103, 1994.

M. Chandesris, I. Melki, N. A. Puel, A. Fieschi, C. Yun et al., Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French National Survey, Medicine, vol.91, pp.1-19, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00717018

E. J. Hillmer, H. Zhang, H. S. Li, and S. S. Watowich, STAT3 signaling in immunity, Cytokine Growth Factor Rev, vol.31, pp.1-15, 2016.

H. Donabedian and J. I. Gallin, The hyperimmunoglobulin E recurrent-infection (Job's) syndrome. A review of the NIH experience and the literature, Medicine, vol.62, pp.195-208, 1983.

Y. Minegishi, M. Saito, M. Nagasawa, H. Takada, T. Hara et al., Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome, J Exp Med, vol.206, pp.1291-301, 2009.

F. L. Van-de-veerdonk, R. J. Marijnissen, R. Marijnissen, L. Joosten, B. J. Kullberg et al., Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency, Clin Exp Immunol, vol.159, pp.57-64, 2010.

D. C. Vinh, J. A. Sugui, A. P. Hsu, A. F. Freeman, and S. M. Holland, Invasive fungal disease in autosomal-dominant hyper-IgE syndrome, J Allergy Clin Immunol, vol.125, pp.1389-90, 2010.

A. Duréault, C. Tcherakian, S. Poiree, E. Catherinot, F. Danion et al., Spectrum of pulmonary aspergillosis in Hyper IgE syndrome with autosomal dominant STAT3 deficiency, J Allergy Clin Immunol Pract, vol.7, pp.1986-95, 2019.

M. E. Da-silva-ferreira, M. Kress, M. Savoldi, M. Goldman, A. Härtl et al., The akuB(KU80) mutant deficient for nonhomologous end joining is a powerful tool for analyzing pathogenicity in Aspergillus fumigatus, Eukaryot Cell, vol.5, pp.207-218, 2006.

R. Shende, S. Wong, S. Rapole, R. Beau, O. Ibrahim-granet et al., Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins, J Biol Chem, vol.293, pp.15538-55, 2018.

J. R. Nesbitt, E. Y. Steves, C. R. Schonhofer, A. Cait, S. S. Manku et al., The Aspergillus fumigatus sialidase (Kdnase) contributes to cell wall integrity and virulence in amphotericin B-treated mice. Front Microbiol, vol.8, p.2706, 2017.

C. Clavaud, A. Beauvais, L. Barbin, H. Munier-lehmann, and J. Latgé, The composition of the culture medium influences the ?-1,3-glucan metabolism of Aspergillus fumigatus and the antifungal activity of inhibitors of ?-1,3-glucan synthesis, Antimicrob Agents Chemother, vol.56, pp.3428-3459, 2012.
URL : https://hal.archives-ouvertes.fr/pasteur-01725799

E. Stephen-victor, A. Karnam, T. Fontaine, A. Beauvais, M. Das et al., Aspergillus fumigatus cell wall ?-(1,3)-glucan stimulates regulatory T-cell polarization by inducing PD-L1 expression on human dendritic cells, J Infect Dis, vol.216, pp.1281-94, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02455452

J. Sarfati, M. Monod, P. Recco, A. Sulahian, C. Pinel et al., Recombinant antigens as diagnostic markers for aspergillosis, Diagn Microbiol Infect Dis, vol.55, pp.279-91, 2006.

L. Chai, F. Van-de-veerdonk, R. J. Marijnissen, S. Cheng, A. L. Khoo et al., Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity, Immunology, vol.130, pp.46-54, 2010.

H. Jolink, R. De-boer, P. Hombrink, R. E. Jonkers, J. T. Van-dissel et al., Pulmonary immune responses against Aspergillus fumigatus are characterized by high frequencies of IL-17 producing T-cells, J Infect, vol.74, pp.81-89, 2017.

R. Agarwal, A. Chakrabarti, A. Shah, D. Gupta, J. F. Meis et al., Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria, Clin Exp Allergy, vol.43, pp.850-73, 2013.

T. M. Eppinger, P. A. Greenberger, D. A. White, A. E. Brown, and C. Cunningham-rundles, Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome, J Allergy Clin Immunol, vol.104, pp.1265-72, 1999.

O. Paccoud, R. Guery, S. Poirée, G. Jouvion, M. E. Bougnoux et al., Aspergillus felis in patient with chronic granulomatous disease, Emerging Infect Dis, vol.25, pp.2319-2340, 2019.

N. Rieber, R. P. Gazendam, A. F. Freeman, A. P. Hsu, A. L. Collar et al., Extrapulmonary Aspergillus infection in patients with CARD9 deficiency, JCI Insight, vol.1, p.89890, 2016.

S. M. Holland, F. R. Deleo, H. Z. Elloumi, A. P. Hsu, G. Uzel et al., STAT3 mutations in the hyper-IgE syndrome, N Engl J Med, vol.357, pp.1608-1627, 2007.

Y. Minegishi, M. Saito, S. Tsuchiya, I. Tsuge, H. Takada et al., Dominantnegative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome, Nature, vol.448, pp.1058-62, 2007.

M. Saito, M. Nagasawa, H. Takada, T. Hara, S. Tsuchiya et al., Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells, J Exp Med, vol.208, pp.235-284, 2011.

R. P. Gazendam, A. Van-de-geer, D. Roos, T. K. Van-den-berg, and T. W. Kuijpers, How neutrophils kill fungi, Immunol Rev, vol.273, pp.299-311, 2016.

J. Beauté, G. Obenga, L. Mignot, L. Mahlaoui, N. Bougnoux et al., Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France, Pediatr Infect Dis J, vol.30, pp.57-62, 2011.

R. P. Gazendam, J. L. Van-hamme, A. Tool, M. Hoogenboezem, J. M. Van-den-berg et al., Human neutrophils use different mechanisms to kill Aspergillus fumigatus conidia and hyphae: evidence from phagocyte defects, J Immunol, vol.196, pp.1272-83, 2016.

M. G. Netea, B. J. Kullberg, and J. Van-der-meer, Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome, Eur J Clin Invest, vol.35, pp.718-739, 2005.

G. Del-prete, A. Tiri, M. E. , D. Carli, M. Macchia et al., Defective in vitro production of gamma-interferon and tumor necrosis factoralpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome, J Clin Invest, vol.84, pp.1830-1835, 1989.

J. D. Milner, J. M. Brenchley, A. Laurence, A. F. Freeman, B. J. Hill et al., Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome, Lancet Infect Dis, vol.452, pp.393-402, 2008.

H. Hebart, Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies, Blood, vol.100, pp.4521-4529, 2002.

A. Teo, I. Herbst, S. Petrou, M. Shiu, K. Y. Mclean et al., Renal allograft recipients fail to increase interferon? during invasive fungal diseases, Am J Transplant, vol.12, pp.3437-3477, 2012.

A. Turnbull, S. A. Teo, I. Stark, J. Rogers, N. J. Rogers et al., Impaired interferon-gamma responses, increased interleukin-17 expression, and a tumor necrosis factor-alpha transcriptional program in invasive aspergillosis, J Infect Dis, vol.200, pp.1341-51, 2009.

H. Nagai, J. Guo, H. Choi, and V. Kurup, Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis, J Infect Dis, vol.172, pp.1554-60, 1995.

E. Roilides, K. Uhlig, D. Venzon, P. A. Pizzo, and T. J. Walsh, Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon, Infect Immun, vol.61, pp.1185-93, 1993.

E. L. Assendorp, M. S. Gresnigt, E. Sprenkeler, J. F. Meis, N. Dors et al., Adjunctive interferon-? immunotherapy in a pediatric case of Aspergillus terreus infection, Eur J Clin Microbiol Infect Dis, vol.37, pp.1915-1937, 2018.

, A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease, N Eng J Med, vol.324, pp.509-525, 1991.

A. Teo, I. A. Shrivastava, S. Petrou, M. A. Taube, D. Dorling et al., Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients, Am J Transplant, vol.10, pp.1796-803, 2010.

C. E. Delsing, M. S. Gresnigt, J. Leentjens, F. Preijers, F. A. Frager et al., Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series, BMC Infect Dis, vol.14, p.166, 2014.

J. H. Rex, J. E. Bennett, J. I. Gallin, H. L. Malech, E. S. Decarlo et al., In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae, J Infect Dis, vol.163, pp.849-52, 1991.

C. L. King, J. I. Gallin, H. L. Malech, S. L. Abramson, and T. B. Nutman, Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma, Proc Natl Acad Sci, vol.86, pp.10085-10094, 1989.

L. De-beaucoudrey, A. Puel, O. Filipe-santos, A. Cobat, P. Ghandil et al., Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells, J Exp Med, vol.205, pp.1543-50, 2008.